Posts Tagged ‘blood’
Fall Infection Control Newsletter
InCo & Associates Quarterly Newsletter
Fall marks the beginning of the Influenza season. For long-term care facilities this signifies numerous flu shots for residents and staff members. Influenza is a common respiratory illness affecting thousands of people worldwide each year. Unfortunately, influenza may be lethal for individuals over the age of 65. Therefore, annual influenza vaccination for individuals over 65 and other residents of long-term care facilities is highly advised.
Individuals infected with the virus may develop body aches, headache, sore throat, sudden fever, chills, and a non-productive cough. For older residents, serious respiratory complications may develop, including pneumonia. Residents with chronic respiratory illnesses, chronic heart disease, kidney failure, and diabetes mellitus are at high risks of serious complications or death. Influenza is transmitted through respiratory droplets and contaminated items. Therefore, if resident s exhibit symptoms of influenza, they should be kept in their room until symptoms subside. Otherwise an influenza outbreak may occur. Staff members working with ill residents should wear appropriate PPEs and increase handwashing to minimize transmission. Vaccination must be administered prior to infection. Antibodies are produced 1-2 weeks after receiving the vaccination. Therefore, individuals exposed to influenza during this 1-2 week interval are not protected. Individuals who are allergic to eggs or who have developed allergic responses to the vaccine in the past should not be vaccinated. Most facilities have policies and procedures regarding the annual influenza vaccination program. Residents may consent to annual vaccinations as part of the conditions of admission.
Influenza Returns
Bloodborne Pathogens Exposure Control Plan (BBP ECP)
OSHA enacted the Bloodborne Pathogens Exposure Control Standard (29CFR 1910.1030) “to reduce occupational exposure to Hepatitis B (HBV), Hepatitis C (HCV), HIV and other bloodborne pathogens” that employees may encounter while performing their job. The Exposure Control Plan (ECP) outlines methods to protect employees from the health hazards associated with BBP and to provide appropriate treatment and counseling in the event of an occupational exposure (I.e. needlestick). The ECP is extremely detailed and outlines the responsibility of specific administrative personnel in the facility. Personnel could include Nursing Supervisors, Employee Health Nurses, Directors of Nursing, Education/Training Instructors and the employees of the facility Influenza vaccination rates among healthcare workers need improvement. Sadly, the staff members who work closest with residents are often the ones who refuse vaccination. Many staff members insist the vaccine will make them sick or mistakenly believe it is unnecessary. Influenza vaccination cannot cause the flu because modern influenza vaccines contain only inactivated viruses.
“Healthcare workers and their employers have a duty to actively promote, implement and comply with influenza immunization recommendations in order to decrease the risk of infection and complications in the vulnerable populations they care for.”
Transmission of influenza between HCWs and vulnerable residents results in significant morbidity and mortality. In a British study, 59% of HCWs with serological evidence of recent influenza infection did not recall having influenza. This suggests that many HCWs experience a sub-clinical infection and potentially transmitted influenza to the residents they cared for.
“The refusal of HCWs to be immunized implies failure on their part in their duty of care to their residents.”
For healthy adults, influenza may be an inconvenience. For the geriatric population, however, influenza may ultimately cause death. Vaccination of HCWs in healthcare facilities has been shown to significantly reduce total patient mortality. Also, effective influenza vaccination programs equate to cost savings for the employer. An influenza outbreak may cost upward of $80,000 to manage. The negative publicity may also cause further problems for the facility long after the outbreak is controlled.
HCWs have an ethical and professional responsibility to protect their residents. Influenza vaccination is one way to fulfill this duty.
“Influenza vaccination cannot cause the flu because the influenza vaccine does not contain live viruses.”
Sources:
Department of Labor OSHA. Final Rule 29 CFR 1910.1030, January 2001.
InCo & Associates Infection Control Policies and Procedures Manual Bloodborne Pathogens Exposure Control Plan.
Sources: Statement on Influenza Vaccination for the 2002-2003 Season. Canada Communicable Disease Report Vol. 28. 1 August 2002.
Influenza Vaccination in Older People. Centre for Reviews and Dissemination, The University of New York. Vol 2, Issue 1, October 1996.
all2003
Urosepsis Vs. UTI: The Confusion Begins
All too often a physician will list a diagnosis of urosepsis. This causes confusion among nursing staff, Infection Control Practitioners (ICPs) and Medical Records personnel. The term urosepsis means different things to different people. “There is a division among physicians themselves as to what the term urosepsis means.”
Literally Uro relates to the urinary tract and sepsis refers to an infection, therefore urosepsis would literally mean an infection of the urinary tract or UTI. However, some physicians were trained to define urosepsis as an infection of the urinary tract that progressed into a systemic infection of the bloodstream. Perhaps this is attributed to the fact that many physicians use the terms sepsis and septicemia interchangeably as well. Again, sepsis, per se, literally means infection and septicemia refers to an “extremely complex disease process leading to progressive multiple organ failure” and death if untreated. While the two definitions have similarities, the treatment for each would vary considerably. Obviously a patient with a systemic infection would present with more severe symptoms and require more aggressive treatment. This equates to a higher level of care and acuity issues, which affect reimbursement. This is the area at which Medical Records becomes involved. The facilities’ Coders have an enormous responsibility to accurately code according to the supporting documentation found in the chart. Failure to do so may result in stiff penalties and charges of fraudulent practices.
“The Office of Inspector General (OIG) is conducting ongoing initiatives on DRGs, including DRG 416 Septicemia.”
The OIG is benchmarking data particularly for healthcare providers and facilities that have abnormally high DRG 416.
“CMS mandates that all medical conditions evaluated, monitored or treated should be reported/coded. DRG and code assignments must be consistent with AHA (American Hospital Association) and CMS regulations. Presently, Medicare has a program in place to help assure accurate DRG assignment referred to as PEEP (Payment Error Prevention Program).”
UTI coded as 599.0 with a DRG 320 could receive payment of $4,861.92. However, a sepsis caused by a UTI would be coded differently and assigned a DRG 416 with a payment of $9,180.67. Sepsis increases the severity of the illness, the LOS (length of stay) and reimbursement. Improper coding may result in hundreds of thousands of dollars in potential losses. From an ICP perspective, many factors are considered in determining the infection. Often a patient will clinically present with severe fever, hypotension, tachycardia, malaise and lethargy. Upon reviewing the laboratory data, if the bacteria in the urinalysis (UA) and the bacteria in the blood cultures (BC) x 2 are identical, this would be considered a septicemia caused by a UTI. On the other hand, not all positive blood cultures mean septicemia. Therefore, physicians use their judgment by evaluating the laboratory data and the patient’s clinical picture. “It should be noted that negative or inconclusive blood culture findings do not preclude a diagnosis of septicemia in patients with clinical evidence of the condition. {…} Coders should learn to recognize the clinical picture of septicemia so as to be able to identify when the diagnosis of septicemia should be questioned.” In the event of a needlestick injury or other occupational exposure, the affected employee must receive counseling and appropriate treatment within a narrow timeframe. It is essential for the Nursing Supervisors and the Directors of Nursing to understand the procedures involved in a post-exposure. Besides stringent timeframes, legal implications are also involved with obtaining consent forms and ensuring confidentiality.
The BBP ECP should be reviewed at least annually or whenever new or modified tasks and procedures are implemented which affect occupational exposure to HCWs. As a related issue, a Hepatitis B vaccination program must be in place within healthcare facilities. Likewise, strict guidelines and timeframes are again applicable. Employees who work in high-risk occupations (I.e. nurses, laboratory staff etc.) must be offered the Hepatitis B vaccination.
Check the Infection Control Policies and Procedures manual for your individual facility.
Sources:
“Bloodstream Infection from UTI (Urosepsis).” Dr. Oster ID Specialist, Scripps Clinic Medical Group San Diego, CA.
“Coding Urosepsis.” Northeast Health Care Quality Foundation.
http://www.medicarequality.org/Review/Tools/urosepsis.htm.
“Coding &DRG Notes. Urosepsis.” Northeast Health Care Quality Foundation. PEEP
“Documentation and Coding of Septicemia.” Ceasar M. Limjoco, M.D.
“General Documentation Issues. UTI/UTI with Sepsis/Urosepsis.”
Http://www.irmcmeded.org
“Instructions for Using the DRG 416 Septicemia Review Worksheet.”
Http://www.tmf.org/files/416inst.pdf.
What is InCo & Associates Doing Now?
INTERNATIONAL Infection Control/Education Consultant
The summer months kept InCo & Associates occupied with new projects.
Linda Spaulding traveled throughout the state of Hawaii educating community clinics about SARS during the month of June. She performed numerous lectures and educated over 30 clinics. She also lectured at the Ilikai hotel during a conference for the hotel association.
She also published an article in Infection Control Today entitled, “SARS, It May Be Here To Stay” Copies of the article can be ordered through www.infectioncontroltoday.com
The education was sponsored by the Department of Health. The goal of the project was to prepare healthcare and hotel workers for SARS.
In July, Linda lectured on the topics of smallpox, monkeypox and SARS in her hometown of Conneaut, Ohio.
This September Linda will be a guess lecturer for the Missouri Hospital Association at their 13th Annual Conference “Essentials of an Effective Infection Control Program”. Her topic is “Education Techniques”.
MARK YOUR CALENDARS
October 23, 2003 InCo and Associates will be providing an all day conference at the Ala Moana Hotel. The topics will include, SARS, Smallpox, Monkeypox, Influenza, Pneumococcal, West Nile Virus, TB, Dengue Fever and How to Develop a Financial Survival Kit.
InCo and Associates feel it is very important for healthcare workers to understand how many infection diseases can affect their families. Are we financially ready to handle the diseases of the future? This will be a very exciting day. Speakers include Jolaine Hao and Linda L. Spaulding of InCo and Associates and Michael Yee from American Express.
For more information please call Linda at 282-5738.
InCo & Associates mission is to design and implement infection control programs &/or provide lectures for our clients to meet the challenges of the 21st century. We provide an opportunity to improve the quality of care by efficiently preventing and managing infections. Our knowledge is based on prevention & control measures that are scientifically based to provide quality programs. Each client’s population is unique and responds differently to preventive and therapeutic interventions; infection control practices must be individualized for each client to achieve maximum benefits of our services.
Linda L Spaulding is considered an expert in the Infection Control arena and currently works with numerous facilities throughout Hawaii, the continental United States, and Japan . Linda was awarded the 2003 National Educator of the Year Award from Infection Control Today magazine.
Bloodborne Pathogens
Bloodborne Pathogens
A Bloodborne Pathogens or blood-borne disease is one that can be spread by contamination by blood.
The most common examples are HIV, hepatitis B, hepatitis C and viral haemorrhagic fevers.
Diseases that are not usually transmitted directly by blood contact, but rather by insect or other vector, are more usefully classified as vector-borne disease, even though the causative agent can be found in blood. Vector-borne diseases include West Nile virus and malaria.
Many blood-borne diseases can also be transmitted by other means.
Since it is difficult to determine what pathogens any given blood contains, and some blood-borne diseases are lethal, standard medical practice regards all blood (and any body fluid) as potentially infective. Blood and Body Fluid precautions are a type of infection control practice that seeks to minimize this sort of disease transmission.
Blood for blood transfusion is screened for many blood-borne diseases.
Needle exchanges are an attempt to reduce the spread of blood-borne diseases in intravenous drug users.
Sharps Waste and Blood-Borne Disease
Sharps waste is a form of medical waste composed of used sharps, which includes any device or object used to pucture or lacerate the skin. Sharps waste is classified as biohazardous waste and must be carefully handled. Common medical materials treated as sharps waste are:
- Syringes & injection devices
- Blades
- Contaminated glass & some plastics
- Qualifying materials
In addition to syringes and injection devices anything attached to them will also be considered sharps waste. Examples of such attachments could be a syringe, tube, or vacutainer. The entire complex is treated as one unit of sharps waste, even though the attached item cannot puncture or lacerate the skin.
The category of blades can include razors, scalpels, x-acto knives, scissors, or any other medical items used for cutting in the medical setting.
Both needles and blades are always treated and handled with the highest concern as sharps waste. This is regardless of if they have been contaminated with biohazardous material. While glass and plastic are considered sharps waste, their handling methods can vary.
Glass and plastic items, which have been contaminated with a biohazardous material, will be treated with the same concern as needles and blades (even if unbroken). If not contaminated, broken glass and plastic is still a sharp waste but does not pose the same public health risk. Therefore broken glass and plastic that has not been contaminated is not handled as delicately. Some common medical items of this category are test tubes, microscope slides, culture dishes, pipettes, and vials.
It should be noted that individual facilities have detailed definitions of specific materials that qualify. The treatment of a particular material as sharps waste may vary from one facility to the next.
Dangers involved in sharps waste
As a biohazardous material, injuries from sharps waste can pose a large public health concern. By penetrating the skin it is possible for this waste to spread blood-borne pathogens. The spread of these pathogens is directly responsible for the transmission of blood-borne diseases such as Hepatitis B (HBV), Hepatitis C (HCV), and HIV. Health care professionals expose themselves to the risk of transmission of these diseases when handling sharps waste.
The large volume handled by health care professionals on a daily basis increases the chance that an injury may occur. Contraction of disease through such an injury will inhibit health care workers from providing their services. This is a cost incurred by society in the promotion of public health. As trained professionals their services are not easily replaced.
The general public can be at direct risk to injuries from sharps waste as well. If these hazardous materials are not separated from standard waste, individuals can unknowingly come in contact with them. In addition, if sharps waste is not disposed, and removed from the environment, then it can be subject to reuse and misuse (both intentional and unintentional). This is especially applicable in the areas of hypodermic needles and blades. The spread of disease through sharps waste is preventable through proper management and disposal.
Sharps waste management & disposal
Extreme care must be taken in the management and disposal of sharps waste. The main goal in sharps waste management is to safely handle all materials until they can be properly disposed. The final step in the disposal of sharps waste is to dispose of them in an autoclave. A less common approach is to incinerate them, typically only chemotherapy sharps waste is incinerated. Steps must be taken along the way to minimize the risk of injury from this material, while maximizing the amount of sharps material disposed. From the moment sharps waste is produced it is to be handled as little as possible. Health care workers are to minimize their interaction with sharps waste by disposing of it in a sealable container. If the sharps waste incorporates an additional part, such as a syringe, tube, or handle the whole unit is disposed together. Attempts by health care workers to disassemble sharps waste is kept to a minimum. Strict hospital protocols and government regulations ensure that hospital workers handle sharps waste safely and dispose effectively.
The self locking and sealable containers are made of plastic so that the sharps waste can not easily penetrate through the sides. The unit is designed so that the whole container can be disposed of with the other biohazardous waste. Single use sharps containers of various sizes are sold throughout the world. These are colored red and labeled for biohazardous sharps waste. They are now commonplace in clinics and hospitals. Large medical facilities may have their own ‘mini’ autoclave in which these sharps containers are disposed of with other medical wastes. This minimizes the distance the containers have to travel and the number of people to come in contact with the sharps waste. Smaller clinic or offices without such facilities are required by federal regulations to hire the services of a company that specializes in transporting and properly disposing of the hazardous wastes.
Some companies, such as BioSystems, provide sharps management and disposal with special re-usable containers in an effort to reduce landfill waste, increase safety and help hospitals and clinics save money by cutting the cost of expensive one use containers.
Bloodborne Pathogens From Wikipedia
For more detailed Bloodborne Pathogen, Bloodborne Disease & Sharps Waste information see Blood-borne disease on Wikipedia.